Correcting Public Misperceptions About Very Low Nicotine Content Cigarettes

NCT ID: NCT04974489

Last Updated: 2022-11-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

1153 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-01

Study Completion Date

2021-08-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Tobacco use is the leading preventable cause of cancer and cancer deaths in the US. While most (69%) smokers want to quit, only 6% succeed in doing so each year. For many smokers, the addictiveness of nicotine makes quitting very difficult. To reduce cigarette smoking and resulting harms, FDA has announced a comprehensive approach to tobacco and nicotine regulation that includes moving toward a very low nicotine content (VLNC) standard for cigarettes. Greatly reduced nicotine levels would facilitate smoking cessation. However, the maximal success of the policy may require public understanding that, although these new cigarettes are less addictive, their high toxicity and carcinogenicity are unchanged. Yet, nearly half of adult smokers incorrectly think smoking VLNC cigarettes is less harmful than smoking current cigarettes (the VLNC misperception). Additionally, 24% of smokers said they would be less likely to quit if a VLNC regulation is enacted. Thus, the VLNC misperception may partially undermine a nicotine reduction policy. Although communication research suggests it is challenging to change people's incorrect understanding, new communication techniques may help reduce the VLNC misperception. In this randomized trial we will examine whether messages about the harm of VLNC cigarettes can reduce the VLNC misperception and increase intention to quit in a nicotine reduction scenario.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study we will assess whether messages about the harm of VLNC cigarettes reduce the misperception that they are less harmful than regular cigarettes.

Recruitment:

We will enroll participants from an existing nationally representative panel.

Informed Consent:

Potential participants are part of an existing nationally representative panel and have already consented to participate in the panel. Before enrolling, participants will also be asked to consent to participate in this study via a consent form included in the study survey.

Randomization:

Survey software will randomly allocate participants to one of the four arms of the study (3 intervention arms or a control arm). Each study arm will have approximately the same number of participants.

Assessment:

Participants will complete a 15-minute survey. The survey will begin with an introduction to the concept of VLNC cigarettes. Then participants will be shown intervention or control messages, and their beliefs will be assessed.

Detailed Description of the Intervention:

Participants will be shown a set of 3 messages about the harms of VLNC cigarettes (intervention arms) or about littering (control arm). Each of the 3 intervention arms use a different theme to attempt to correct the VLNC misperception.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tobacco Use, Cigarette Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Emotion-based messages about the harm of VLNC

Group Type EXPERIMENTAL

Emotion-based messages about the harm of VLNC

Intervention Type BEHAVIORAL

Participants in this arm will receive 3 emotion-based messages about the harm of VLNC during the survey data collection.

Continued-harm-framed messages about the harm of VLNC

Group Type EXPERIMENTAL

Continued-harm-framed messages about the harm of VLNC

Intervention Type BEHAVIORAL

Participants in this arm will receive 3 continued-harm-framed messages about the harm of VLNC during the survey data collection.

Myth-refuting messages about the harm of VLNC

Group Type EXPERIMENTAL

Myth-refuting messages about the harm of VLNC

Intervention Type BEHAVIORAL

Participants in this arm will receive 3 myth-refuting messages messages about the harm of VLNC during the survey data collection.

Control messages about littering

Group Type ACTIVE_COMPARATOR

Control messages about littering

Intervention Type BEHAVIORAL

Participants in this arm will receive 3 control messages about littering during the survey data collection.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Emotion-based messages about the harm of VLNC

Participants in this arm will receive 3 emotion-based messages about the harm of VLNC during the survey data collection.

Intervention Type BEHAVIORAL

Continued-harm-framed messages about the harm of VLNC

Participants in this arm will receive 3 continued-harm-framed messages about the harm of VLNC during the survey data collection.

Intervention Type BEHAVIORAL

Myth-refuting messages about the harm of VLNC

Participants in this arm will receive 3 myth-refuting messages messages about the harm of VLNC during the survey data collection.

Intervention Type BEHAVIORAL

Control messages about littering

Participants in this arm will receive 3 control messages about littering during the survey data collection.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Current Cigarette Smoker
* Age 18 or older
* Enrolled in existing nationally representative panel where recruitment is based

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

UNC Lineberger Comprehensive Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

M. Justin Byron, PhD

Role: PRINCIPAL_INVESTIGATOR

University of North Carolina, Chapel Hill

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of North Carolina, Chapel Hill

Chapel Hill, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R21CA234968

Identifier Type: NIH

Identifier Source: secondary_id

View Link

19-1284

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Smoking Cessation Intervention for Thoracic Patients
NCT00580398 COMPLETED PHASE1/PHASE2
Effective Ads for Quitting Smoking
NCT06485479 COMPLETED NA
Health Communications for Adults Smoking Nondaily
NCT07296848 NOT_YET_RECRUITING NA
Motivating Change in Aging Smokers
NCT05194917 COMPLETED NA